Puma Biotechnology Inc
NASDAQ:PBYI

Watchlist Manager
Puma Biotechnology Inc Logo
Puma Biotechnology Inc
NASDAQ:PBYI
Watchlist
Price: 2.75 USD
Market Cap: 135m USD
Have any thoughts about
Puma Biotechnology Inc?
Write Note

Intrinsic Value

The intrinsic value of one PBYI stock under the Base Case scenario is 4.48 USD. Compared to the current market price of 2.75 USD, Puma Biotechnology Inc is Undervalued by 39%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PBYI Intrinsic Value
4.48 USD
Undervaluation 39%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Puma Biotechnology Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
PBYI
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for PBYI cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about PBYI?
Bearish
Neutral
Bullish

Fundamental Analysis

2.75 USD
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Puma Biotechnology Inc
US
Biotechnology
Market Cap
134.9m USD
IPO
Mar 21, 2012
Employees
196
United States of America
Market Cap
134.9m USD
Industry
Biotechnology
IPO
Mar 21, 2012
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Puma Biotechnology Inc

Provide an overview of the primary business activities
of Puma Biotechnology Inc.

What unique competitive advantages
does Puma Biotechnology Inc hold over its rivals?

What risks and challenges
does Puma Biotechnology Inc face in the near future?

Has there been any significant insider trading activity
in Puma Biotechnology Inc recently?

Summarize the latest earnings call
of Puma Biotechnology Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Puma Biotechnology Inc.

Provide P/S
for Puma Biotechnology Inc.

Provide P/E
for Puma Biotechnology Inc.

Provide P/OCF
for Puma Biotechnology Inc.

Provide P/FCFE
for Puma Biotechnology Inc.

Provide P/B
for Puma Biotechnology Inc.

Provide EV/S
for Puma Biotechnology Inc.

Provide EV/GP
for Puma Biotechnology Inc.

Provide EV/EBITDA
for Puma Biotechnology Inc.

Provide EV/EBIT
for Puma Biotechnology Inc.

Provide EV/OCF
for Puma Biotechnology Inc.

Provide EV/FCFF
for Puma Biotechnology Inc.

Provide EV/IC
for Puma Biotechnology Inc.

Show me price targets
for Puma Biotechnology Inc made by professional analysts.

What are the Revenue projections
for Puma Biotechnology Inc?

How accurate were the past Revenue estimates
for Puma Biotechnology Inc?

What are the Net Income projections
for Puma Biotechnology Inc?

How accurate were the past Net Income estimates
for Puma Biotechnology Inc?

What are the EPS projections
for Puma Biotechnology Inc?

How accurate were the past EPS estimates
for Puma Biotechnology Inc?

What are the EBIT projections
for Puma Biotechnology Inc?

How accurate were the past EBIT estimates
for Puma Biotechnology Inc?

Compare the revenue forecasts
for Puma Biotechnology Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Puma Biotechnology Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Puma Biotechnology Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Puma Biotechnology Inc compared to its peers.

Compare the P/E ratios
of Puma Biotechnology Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Puma Biotechnology Inc with its peers.

Analyze the financial leverage
of Puma Biotechnology Inc compared to its main competitors.

Show all profitability ratios
for Puma Biotechnology Inc.

Provide ROE
for Puma Biotechnology Inc.

Provide ROA
for Puma Biotechnology Inc.

Provide ROIC
for Puma Biotechnology Inc.

Provide ROCE
for Puma Biotechnology Inc.

Provide Gross Margin
for Puma Biotechnology Inc.

Provide Operating Margin
for Puma Biotechnology Inc.

Provide Net Margin
for Puma Biotechnology Inc.

Provide FCF Margin
for Puma Biotechnology Inc.

Show all solvency ratios
for Puma Biotechnology Inc.

Provide D/E Ratio
for Puma Biotechnology Inc.

Provide D/A Ratio
for Puma Biotechnology Inc.

Provide Interest Coverage Ratio
for Puma Biotechnology Inc.

Provide Altman Z-Score Ratio
for Puma Biotechnology Inc.

Provide Quick Ratio
for Puma Biotechnology Inc.

Provide Current Ratio
for Puma Biotechnology Inc.

Provide Cash Ratio
for Puma Biotechnology Inc.

What is the historical Revenue growth
over the last 5 years for Puma Biotechnology Inc?

What is the historical Net Income growth
over the last 5 years for Puma Biotechnology Inc?

What is the current Free Cash Flow
of Puma Biotechnology Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Puma Biotechnology Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Puma Biotechnology Inc

Current Assets 156.8m
Cash & Short-Term Investments 96.7m
Receivables 54.6m
Other Current Assets 5.4m
Non-Current Assets 63.9m
PP&E 6m
Intangibles 53.6m
Other Non-Current Assets 4.3m
Current Liabilities 110.4m
Accounts Payable 7.5m
Accrued Liabilities 56m
Other Current Liabilities 46.9m
Non-Current Liabilities 39.2m
Long-Term Debt 32.7m
Other Non-Current Liabilities 6.5m
Efficiency

Earnings Waterfall
Puma Biotechnology Inc

Revenue
243.6m USD
Cost of Revenue
-74.8m USD
Gross Profit
168.8m USD
Operating Expenses
-136.4m USD
Operating Income
32.4m USD
Other Expenses
-9.2m USD
Net Income
23.2m USD

Free Cash Flow Analysis
Puma Biotechnology Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PBYI Profitability Score
Profitability Due Diligence

Puma Biotechnology Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional ROE
ROIC is Increasing
62/100
Profitability
Score

Puma Biotechnology Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

PBYI Solvency Score
Solvency Due Diligence

Puma Biotechnology Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
42/100
Solvency
Score

Puma Biotechnology Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PBYI Price Targets Summary
Puma Biotechnology Inc

Wall Street analysts forecast PBYI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PBYI is 4.42 USD with a low forecast of 2.02 USD and a high forecast of 7.35 USD.

Lowest
Price Target
2.02 USD
27% Downside
Average
Price Target
4.42 USD
61% Upside
Highest
Price Target
7.35 USD
167% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PBYI?

Click here to dive deeper.

Dividends

Puma Biotechnology Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PBYI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

PBYI Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one PBYI stock?

The intrinsic value of one PBYI stock under the Base Case scenario is 4.48 USD.

Is PBYI stock undervalued or overvalued?

Compared to the current market price of 2.75 USD, Puma Biotechnology Inc is Undervalued by 39%.

Back to Top